BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34694179)

  • 1. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
    Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
    J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
    Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
    Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
    Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
    Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
    J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study.
    Wikström I; Lindell M; Sanner K; Wilander E
    Br J Cancer; 2011 Jul; 105(3):337-9. PubMed ID: 21730977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 11. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
    Andersson S; Belkić K; Mints M; Östensson E
    J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches.
    Ivanus U; Jerman T; Fokter AR; Takac I; Prevodnik VK; Marcec M; Gajsek US; Pakiz M; Koren J; Celik SH; Kramberger KG; Klopcic U; Kavalar R; Zatler SS; Kuzmanov BG; Florjancic M; Nolde N; Novakovic S; Poljak M; Zakelj MP
    Radiol Oncol; 2018 Sep; 52(4):399-412. PubMed ID: 30216191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
    Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
    PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.
    Drysdale H; Marlow LA; Lim A; Sasieni P; Waller J
    J Med Screen; 2022 Sep; 29(3):194-202. PubMed ID: 35389282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
    Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
    Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
    Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.
    Ilangovan K; Kobetz E; Koru-Sengul T; Marcus EN; Rodriguez B; Alonzo Y; Carrasquillo O
    J Womens Health (Larchmt); 2016 Sep; 25(9):944-51. PubMed ID: 26890012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.